Jdron-T 1.125 Injection
Marketer
Jayden Healthcare Pvt. Ltd.
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Jdron-T 1.125 Injection
Tridon-X 1.125 Injection, a multi-component medication, combats various bacterial infections. Its action inhibits microbial proliferation, thereby controlling infection spread. Administration must be overseen by a healthcare provider. Consistent adherence to the prescribed schedule is crucial; completing the full course is vital, even with symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) demand prompt medical help. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration promote faster recovery. Your doctor may order laboratory and diagnostic tests to monitor treatment response.
Primary Ingredients of Jdron-T 1.125 Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Jdron-T 1.125 Injection
Infections caused by bacteria
Major Benefits of Jdron-T 1.125 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Jdron-T 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Jdron-T 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Jdron-T 1.125 Injection works:
Ceftriaxone and Tazobactum, the components of Jdron-T 1.125 Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Jdron-T 1.125 Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Jdron-T 1.125 is typically deemed safe for use in pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data from human studies, however, remain scarce.
Breast feedingCAUTION
The administration of Jdron-T 1.125 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Jdron-T 1.125 Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Jdron-T 1.125 Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Patients with severe hepatic impairment should receive Jdron-T 1.125 Injection cautiously, potentially requiring dosage modification. For patients with mild to moderate liver disease, dosage alteration of Jdron-T 1.125 Injection is unnecessary; however, physician consultation is advised.
What if you forget to take Jdron-T 1.125 Injection :
Omitting a scheduled dose of Jdron-T 1.125 Injection warrants contacting your physician.
Facts to Know About Jdron-T 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently